Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
OncXerna Therapeutics
OncXerna Therapeutics provides precision medicine through an RNA-based biomarker platform.
Sector
Subsector
Location
total rounds
total raised
Odyssey Therapeutics
Odyssey Therapeutics is a biotech company that develops next-generation immunomodulators and oncology medicines.
Sector
Subsector
Keywords
Location
total rounds
total raised
Kura Oncology
Kura Oncology develops precision medicines for solid tumors and blood cancers.
Sector
Subsector
Keywords
Location
total rounds
total raised
Blueprint Medicines
Blueprint Medicines develops personalized cancer therapies using highly selective kinase inhibitors.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 16.07.2024. Their latest investor Lightspeed Venture Partners. Their latest round Series C
Lightspeed Venture Partners
Lightspeed Venture Partners is a multi-stage venture capital firm that invests in disruptive innovations and trends in various sectors.
Sector
Subsector
Location
count Of Investments
count Of Exists
EcoR1 Capital
EcoR1 Capital is a biotech-focused investment advisory firm based in San Francisco.
Sector
Subsector
Location
count Of Investments
count Of Exists
Vida Ventures
Vida Ventures is a life sciences company that funds biomedical innovations to improve patients' lives.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Boxer Capital
Boxer Capital supports biotech public companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Omega Funds
Omega Funds is a global life sciences-based investment firm that specializes in direct secondary transactions.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Vida Ventures
Vida Ventures is a life sciences company that funds biomedical innovations to improve patients' lives.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Atlas Venture
Atlas Venture invests in biotech startups with seed and early stage venture investments.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Co-Investors
Investors18
Number of lead investors
Number of investors
Lightspeed Venture Partners
Lightspeed Venture Partners is a multi-stage venture capital firm that invests in disruptive innovations and trends in various sectors.
Sector
Subsector
Location
count Of Investments
count Of Exists
Shelley Chu
Shelley joined Abingworth in 2015 and invests across a broad range of therapeutic areas and stages of development from start-ups to late-stage. She serves on the Board of Directors for Tizona Therapeutics, SFJ Pharmaceuticals and VenatoRx, and co-led Abingworth’s investments in IFM Therapeutics, Inc (acquired by Bristol-Myers Squibb), IFM Therapeutics LLC and IFM Tre. Shelley has over 15 years of operating and investment experience in the biopharmaceutical industry, including most recently Gilead where she led R&D Strategy and Business Development in Oncology, Immunotherapy and Hepatitis B. Previously Shelley invested and co-founded biotechnology companies at Frazier Healthcare Ventures. Earlier in her career she was an investment professional at Flagship Ventures and a management consultant to healthcare and biotech companies at McKinsey. Shelley holds an MD and PhD in Biochemistry and Biophysics from UCSF, and received her BA in Molecular Biology from Princeton University. She is a first author of publications in Science and other prominent journals, a Co-Chair of the Princeton Alumni School Committee and a member of the Advisory Committee for BIO’s Investor Forum.
current job
Nextech Invest
Nextech Invest is a venture capital and private equity firm that focuses on precision therapies in oncology.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Logos Capital
Logos Capital is a San Francisco VC firm investing in biotech startups.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders4
Keith Flaherty
Keith Flahert is the Physcian at Massachusetts General Hospital.
current job
organization founded
Keith Flaherty
Gary Glick
Gary D. Glick is the Founder and Executive Chair at IFM Therapeutics.
current job
Gary Glick
Employee Profiles8
Chih-Chiang Tsou
Director, Head of Chemical Biology Informatics
Activity
Recent News6
The graph reveals the ratio (%) of positive news articles in a chosen time range